HOME >> BIOLOGY >> NEWS
UCLA's California NanoSystems Institute partners with Abraxis BioScience

The California NanoSystems Institute (CNSI) at UCLA today announced a partnership with the integrated global biopharmaceutical company Abraxis BioScience Inc. to collaborate on nanobiotechnology research for the advancement of new technologies in medicine.

Abraxis BioScience will collaborate with the institute and its team of leading researchers to capitalize on the recent explosion in nanoscience and to chart the future of nanotechnology within biotechnology. Abraxis has agreed to contribute $10 million over 10 years to fund collaborative projects at UCLAs new CNSI building. The Abraxis/CNSI Research Collaboration Lab will focus on translational science, quickly translating scientific discoveries into practical applications.

Abraxis BioScience has joined the CNSI Partners Program and is the institutes first partner in the area of pharmaceuticals and biotechnology. The partnership provides CNSI and Abraxis researchers the opportunity to jointly pursue innovative approaches to the diagnosis and treatment of life threatening diseases, leveraging the complementary resources and skills of both organizations. To further support the partnership, visiting scholars from other institutions will also participate in the collaborative research programs.

We are eager to collaborate with Abraxis BioScience. Cross-disciplinary collaboration is vital to our research efforts, said Fraser Stoddart, CNSI director and UCLAs Fred Kavli Professor of Nanosystems Sciences. The exciting thing about nanosystems research is that it is bringing about a sea change in the academic environment it is breaking down the barriers between disciplines to achieve a seamless integration between chemistry, physics, biology and engineering in all of their different forms.

We are very excited about this research collaboration with the CNSI and believe this type of relationship emphasizes our commitment toward pursuing innovative research and forging new paradigms
'"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
26-Jul-2007


Page: 1 2

Related biology news :

1. News conference on plant diseases and issues important to California
2. Expert to provide update after worst tomato virus hits California
3. Plant diseases and issues that are of importance to Californias economy and agriculture
4. Californians urged to help reduce spread of Sudden Oak Death
5. Salmon tracking program expands to California
6. Regulating Californian stem cell research, and more
7. Brown rot shrivels prune production in California
8. Disease opened door to invading species in California
9. Altered ocean currents disturb ecosystem off Northern California and Oregon coast
10. California scientists find natural way to control spread of destructive Argentine ants
11. University of California, San Diego-led team discovers how we detect sour taste

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... (PRWEB) , ... August 11, 2020 , ... ... subsidiary based in Princeton, NJ, have entered into license agreements with Housey Pharma’s ... development. Both Roche and J&J have annual Research and Development spending in ...
(Date:8/5/2020)... PENSACOLA, Fla. (PRWEB) , ... August 05, 2020 , ... ... to cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly ... a defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... , ... August 03, 2020 , ... ... today announced Jim Corrigan, President and CEO has been named one of the ... cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how they ...
(Date:7/31/2020)... STATION, Texas (PRWEB) , ... July 29, 2020 ... ... cleanroom solutions today announced the launch of its new tagline, “BUILDING FOR LIFE.” ... the biopharmaceutical industry and around the globe, requiring fast track capacity to provide ...
(Date:7/31/2020)... and SOMERSET, N.J (PRWEB) , ... July 29, ... ... genome editing company, and Catalent, the leading global provider of advanced delivery technologies, ... health products, today announced that they have entered into a strategic partnership whereby ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... for the life sciences industry, today announced the release of its signature ... for Medical Science Liaisons (MSLs) and other field medical professionals. , ...
Breaking Biology Technology:
Cached News: